Klotho Neurosciences, Inc. KLTO
Set alert
0.38 USD 0.00 0.00%
As of Mar 16, 3:59 PM ET
0.37 Day range 0.41
0.26 52-week range 13.10
- YTD
- +31.83%
- 1 year
- +34.72%
- Open
- 0.406
- Prev close
- 0.381
- Mkt cap
- 9.86M
- Vol
- 95.00K
- Avg vol
- 522.99K
- EPS
- -0.32
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.37
- High
- 0.41
- Forward P/E
- 0.00
- Beta
- 0.06
- Short ratio
- 0.34
- Inst. own
- 11.42%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.45094
- 200-d avg
- 3.47
- 1y target
- 0.00
Financial health
Altman Z-Score
-0.00 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -1.3×
FY 2021 5y median -936× FY 2025
P/S 0.0×
FY 2021 5y median 0.0× FY 2025
P/B 1.5×
FY 2021 5y median 913× FY 2025
P/FCF -2.4×
FY 2021 5y median -1484× FY 2025
EV/EBITDA -1.0×
FY 2021 5y median -970× FY 2025
EV/Sales 0.0×
FY 2021 5y median 0.0× FY 2025
FCF Yield -41.8%
FY 2021 5y median -0.1% FY 2025
Profitability
Gross Margin 0.0%
FY 2021 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2021 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2021 5y median 0.0% FY 2025
ROE -111.5%
FY 2021 5y median -111.5% FY 2025
ROIC -75.1%
FY 2021 5y median -75.1% FY 2025
ROA -110.0%
FY 2021 5y median -106.5% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2021 FY 2025
Operating Income -29.0%
FY 2021 FY 2025
EPS (diluted) 31.3%
FY 2021 FY 2025
Free Cash Flow -90.8%
FY 2021 FY 2025
Financial Health
Current Ratio 95.0×
FY 2021 5y median 0.2× FY 2025
Quick Ratio 95.0×
FY 2021 5y median 0.2× FY 2025
Debt / Equity 0.0×
FY 2021 5y median 0.2× FY 2025
Net Debt / EBITDA 1.0×
FY 2021 5y median -0.0× FY 2025
Interest Coverage -3.1×
FY 2021 5y median -8.3× FY 2025
Dividends
Dividend Yield 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31